| Literature DB >> 21624117 |
David I Ojakaa1, Peter Ofware, Yvonne W Machira, Emmanuel Yamo, Yvette Collymore, Antoinette Ba-Nguz, Preeti Vansadia, Allison Bingham.
Abstract
BACKGROUND: Malaria is a leading cause of morbidity and mortality in children younger than 5 years in Kenya. Within the context of planning for a vaccine to be used alongside existing malaria control methods, this study explores sociocultural and health communications issues among individuals who are responsible for or influence decisions on childhood vaccination at the community level.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21624117 PMCID: PMC3120733 DOI: 10.1186/1475-2875-10-147
Source DB: PubMed Journal: Malar J ISSN: 1475-2875 Impact factor: 2.979
Sampling framework and final sample size
| Busia region | South Coast region/Mombasa district | Number of events |
|---|---|---|
| Mothers 50+ years old | Mothers 50+ years old | |
| Fathers 50+ years old | Fathers 50+ years old | |
| Mothers 25-49 years old (2 groups) | Mothers 25-49 years old (2 groups) | |
| Fathers 25-49 years old | Fathers 25-49 years old | |
| Mothers 18-24 years old | Mothers 18-24 years old | |
| Fathers 18-24 years old | Fathers 18-24 years old | |
| Mothers 18-49 years old | Mothers 18-49 years old | |
| Fathers 18-49 years old | Fathers 18-49 years old | |
| Community health workers | Community health workers | 20 |
| Woman leader, youth leader, assistant chief, pastor, teacher, shopkeeper, traditional birth attendant, civil society organization representative, district public health officer, district nutritionist | Woman leader, youth leader, chief, pastor, imam, traditional birth attendant, civil society organization representative, teacher, local pharmacist, district public health officer, district medical officer, district public health nurse | 22 |
| Mothers in an antenatal clinic (3) | Mothers in an antenatal clinic (3) | |
| Mothers in a child welfare center (3) | Mothers in a child welfare center (3) | |
| Mothers with febrile children (3) | Mothers with febrile children (3) | 18 |
| Total | 60 events | |
Themes explored in the study
| Theme | Thematic areas explored |
|---|---|
| 1. Perceptions and experiences with malaria | • Perceptions of women and men around malaria. |
| 2. Perceptions and experiences with child immunization | • Community experiences with vaccination programs and the health system. |
| 3. Considerations for a future malaria vaccine | • Reactions to the prospect of a new vaccine. |
Those likely to motivate others to access vaccination services
| Primary influencers | Secondary influencers |
|---|---|
| • Community health workers | • Mothers-in-law |
| • Health care providers (doctors, nurses) | • Grandmothers |
| • Neighbors | • Councils of elders |
| • Village elders | • Traditional healers |
| • Mass media | • School-going children |
| • Local or provincial government administrations (including chiefs and assistant chiefs) | • Mother-to-mother support groups• |
| • Ministry of Medical Services | • Representatives of non-registered immigrants and nomadic communities |
| • Ministry of Public Health and Sanitation | • The elite within society (professionals/professional organizations) |
Information needs related to a future malaria vaccine.
| Information requested by all participants |
|---|
| • Malaria prevalence rates. |
| • Expected benefits of the vaccine. |
| • Whether the vaccine would prevent or cure disease. |
| • Whether the vaccine would provide complete or partial protection. |
| • Number of doses needed. |
| • Mode of administration. |
| • Possible side effects of the vaccine. |
| • How the vaccine would work; how it would differ from other vaccines in use. |
| • Whether the vaccine would be for children only or for pregnant women and others as well. |
| • Ages of children to be vaccinated. |
| • Duration of protection and need for booster doses. |
| • Whether the vaccine would be offered at anytime or only during malaria outbreaks. |
| • Where vaccinations would take place. |
| • Whether people would have to pay for the vaccine. |
| • Whether vaccination would be accompanied by incentives (such as bed nets). |
| • Manufacturer of the vaccine. |
| • Where and when the vaccine was tested and the outcome. |
| • Whether the vaccine was the result of a governmental or nongovernmental initiative and which governments support it. |
| • How to administer the vaccine. |
| • Dosage. |
| • Vaccine storage and handling requirements. |
| • Expiry date. |